8Kuroiwa T, Kajimoto Y, Ohta T, et al. Development of afluorescein opera- tive microscope for use during malignant glioma surgery-a technical note and prelim inary report[ J]. Surg Neurol,1998 ;50( 1 ) :41-9.
9Moore GE, Peyton WT, French LA, et al. The clinical use of fluorescein in neurosurgery-the localization of brain tumors [ J ]. J Neurosurg, 1948; 5:392.
10Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of ma- lignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence [J]. Neurosurgery, 1998 ;42:518.
6Olzowy B,Hundt CS,Stocker S,et al.Photoirradiation therapy of experimental malignant gioma with 5-aminolevu-linic acid[J].J Neurosurg,2002,97:970-976.
7Kaye AH,Hill JS.Photodynamic therapy of bran tumours[J].Ann Acad Med Singapore,1993,22:470-481.
8ALBERT F K,FORST1NG M,SARTOR K,et al.Early postoperative magnetic resonance imaging after resection of malignant glioma:objective evaluation of residual tumor and its influence on regrowth and prognosis[J].Neurosurgery,1994,34(1):45-61.
9BLACK P M,MORIARTY T,ALEXANDER E Ⅲ,et al.Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications[J].Neurosurgery,1997,41(4):831-845.
10MORIARTY T M,QUINONES-HINOJOSA A,LARSON P S,et al.Frameless stereotactic neurosurgery using intraoperative magnetic resonance imaging:stereotactic brain biopsy[J].Neurosurgery,2000,47(5):1138-1146.
6Diez Valle R,Tejada Solis S, Idoate Gastearena MA, et al. Surgeryguided by 5-aminolevulinic fluorescence in glioblas- toma: volumetricanalysis of extent of resection in single- center experience [ J]. J Neurooncol, 2011,102 ( 1 ) : 105- 113.
7Castro MG, Candolfi M, kroeger K, et al. Gene therapy and targeted toxins for glioma[ J]. Curr Gene Ther,2011,11 (3) :155-180.
8Reisoli E, Gambini E, Appolloni L, et al. Efficacy of HER2 retargeted herpes simplexvirus as therapy for high-grade glioma in immunocompetent mice[ J]. Cancer Gene Ther, 2012,19( 11 ) :788-795.
9Varda-Bloom N,Hodish 1, Shaish A, et al. Specific induc- tion of tumor neovaseulature death by modiied routine PPE-1 promoter armed with HSV-TK [ J ]. Pathobiology, 2008,75 (6) : 346-355.
10Chiocca EA,Smith KM,Mckinney B ,et al. A phase I trial of Ad. hIFN-beta gene therapy for glioma[ J]. Mol Ther, 2008,16 (3) :618-626.
